1564. Lower Rates of Epstein–Barr Virus (EBV) Viremia in Pediatric Solid Organ Transplant (SOT) Recipients Who Received Valganciclovir Prophylaxis

BACKGROUND: Antiviral prophylaxis to prevent PTLD remains controversial, but some data suggest that valganciclovir or ganciclovir ([val]ganciclovir) use in EBV high-risk pediatric renal transplants reduces EBV viremia. We evaluated the impact of [val]ganciclovir on EBV viremia and post-transplant ly...

Descripción completa

Detalles Bibliográficos
Autores principales: Moulton, Elizabeth A, Karandikar, Manjiree, Bond, Sheila, Burchett, Sandra, Sharma, Tanvi, Marty, Francisco M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252575/
http://dx.doi.org/10.1093/ofid/ofy210.1392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252575/
http://dx.doi.org/10.1093/ofid/ofy210.1392

Ejemplares similares